The United States represents the largest contributor to the Mass Spectrometry Market, supported by its advanced healthcare infrastructure, strong pharmaceutical and biotechnology industries, and extensive research and development activities. The country benefits from the presence of leading life sciences companies, academic institutions, government-funded research programs, and clinical...